Xalud Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Xalud Therapeutics's estimated annual revenue is currently $8.1M per year.
- Xalud Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Xalud Therapeutics has 52 Employees.
- Xalud Therapeutics grew their employee count by 148% last year.
Xalud Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Technical Officer | Reveal Email/Phone |
3 | Chief Development Officer | Reveal Email/Phone |
4 | VP Research And Development | Reveal Email/Phone |
5 | SVP Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
6 | SVP, Global Commercial Development | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Senior Director, Research and Development | Reveal Email/Phone |
9 | Chief Operating Officer | Reveal Email/Phone |
10 | Director Clinical Operations | Reveal Email/Phone |
Xalud Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Xalud Therapeutics?
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.
keywords:N/A
N/A
Total Funding
52
Number of Employees
$8.1M
Revenue (est)
148%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xalud Therapeutics News
Xalud Therapeutics is a biotechnology company developing a DNA-delivered therapy platform to treat pathologic inflammation through immune...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.4M | 52 | -31% | N/A |
#2 | $6.6M | 52 | 27% | N/A |
#3 | $15M | 52 | -9% | N/A |
#4 | $10.3M | 52 | -15% | N/A |
#5 | $11.7M | 52 | -13% | N/A |